# Single Dosing Clinical Trial of HL151

> **NCT02682745** · PHASE1 · COMPLETED · sponsor: **Hanlim Pharm. Co., Ltd.** · enrollment: 30 (actual)

## Conditions studied

- Rhinitis, Allergic, Perennial

## Interventions

- **DRUG:** HL151
- **DRUG:** TALION tab.

## Key facts

- **NCT ID:** NCT02682745
- **Lead sponsor:** Hanlim Pharm. Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-01-15
- **Primary completion:** 2016-02-12
- **Final completion:** 2016-02-12
- **Target enrollment:** 30 (ACTUAL)
- **Last updated:** 2018-08-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02682745

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02682745, "Single Dosing Clinical Trial of HL151". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT02682745. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*